Loading...
NPI 1285920694 · Lees Summit, MO · Hematology & Oncology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Zhineng Yang is a hematology & oncology physician provider located in Lees Summit, Missouri. This profile covers 65 Medicare and 5 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Zhineng Yang |
| Address | 110 Ne Saint Lukes Blvd Ste 500 |
| City | Lees Summit |
| State | MO |
| ZIP | 64086 |
| Taxonomy | Hematology & Oncology Physician |
| NPI Enumerated | June 23, 2011 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $413.4K |
| Medicaid | $6.9K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
65 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 890 | $90 | $83.9K |
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 50 | $1,090 | $55.6K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 39,750 | $1 | $39.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 190 | $140 | $25.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 250 | $100 | $24.7K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 4,060 | $10 | $20.3K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 50 | $410 | $19.8K |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 80 | $170 | $13.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 150 | $60 | $9.4K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 780 | $10 | $9.4K |
Showing 1–10 of 65
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 65 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
65 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 88185 | 6 | 10 | 560 | $20 | $22.8K |
| J1439 | 2 | 20 | 21,000 | $1 | $22.2K |
| 96413 | 43 | 160 | 140 | $100 | $19.1K |
| J9217 | 55 | 70 | 100 | $130 | $17.7K |
| J0885 | 1 | 10 | 2,410 | $10 | $15.7K |
| 78815 | 81 | 160 | 50 | $150 | $15.4K |
| A9552 | 10 | 20 | 60 | $230 | $14.7K |
| 99214 | 175 | 8,960 | 100 | $80 | $13.9K |
| 74177 | 380 | 560 | 130 | $70 | $11.4K |
| 99232 | 4,093 | 4,320 | 90 | $60 | $10.8K |
Showing 1–10 of 65
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
5 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 210 | $30 | $5.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 20 | $40 | $710 |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 30 | $10 | $300 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 30 | $1 | $30 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 20 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Missouri providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Missouri median
5 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 41 | 40 | 530 | $130 | $144.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,632 | 3,170 | 230 | $70 | $128.1K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 81 | 90 | 490 | $40 | $52.5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 29 | 40 | 70 | $1 | $1.4K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 2 | 10 | 20 | $1 | $10 |
Other providers in the same ZIP code as Zhineng Yang, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Rediscover | MO | Community/Behavioral Health Agency | $0 | $213.9M |
| Children's Mercy-community Choice Pediatrics | MO | Pediatrics Physician | $0 | $9M |
| Kc Pain Asc, LLC | MO | Ambulatory Surgical Clinic/Center | $2.5M | $12.5K |
| Saint Luke's Surgicenter - Lee's Summit | MO | Ambulatory Surgical Clinic/Center | $2.3M | $0 |
| David Fieleke | MO | Dermatology Physician | $823.2K | $0 |
| Sarah Foster | MO | Family Nurse Practitioner | $675.5K | $0 |
| Kevin Skelsey | MO | Ophthalmology Physician | $479.1K | $0 |
| Gary Mcewen | MO | Dermatology Physician | $379.6K | $0 |
| Michael Hellman | MO | Orthopaedic Surgery Physician | $313K | $0 |
| Wesley Frevert | MO | Sports Medicine (Orthopaedic Surgery) Physician | $232.3K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.